Skip to Content
PR Newswire

Rootine Partners with NFL Defensive Star Brian Burns

Rootine Partners with NFL Defensive Star Brian Burns

Rootine Partners with NFL Defensive Star Brian Burns

The data-driven nutrition company illustrates the correlation between precision nutrition and peak performance signing an exemplary athlete

PR Newswire

NASHVILLE, Tenn., Aug. 12, 2021

NASHVILLE, Tenn., Aug. 12, 2021 /PRNewswire/ -- On the heels of their $3 million seed round, Rootine announced today they have partnered with NFL defensive standout Brian Burns. Burns understands the importance of properly fueling his body to increase performance, improve stamina, and "keep laser-focused on the field." Burns embodies the Rootine ethos. He knows what it takes to play at his optimal level on and off the field.

Burns is entering his third year in the league. With that experience he understands how to read his body. Rootine's Head of Brand, Lily Hecht-Leavitt, speaks to why Burns is an ideal brand ambassador: "Brian is an elite athlete and a creative and humble individual who pushes ego aside, fully engaging with the brand. Brian has fine tuned his body through perseverance, diligence, and precision nutrition."

Burns echoes Hecht-Leavitt's enthusiasm, "As a professional athlete, we're constantly being hit up to represent a brand so it takes something special to catch my attention. Rootine stood out to me because they create a completely customized formula based on health data. They use the latest technologies to personalize micronutrients to achieve optimal performance."

This pivotal partnership is the first type for both parties. They look forward to bringing precision nutrition to the forefront of the intersection between health, technology, and sports.

Rootine CEO and co-founder, Rachel Soper Sanders shares, "The partnership is furthering our mission and elevating the Rootine member experience by reaching new and wider audiences. Brian is representative of our community members: an individual leveraging health data to make informed decisions in order to perform at his optimal level."

Rootine unlocks better health and daily performance with precision nutrition. Rootine's first product focuses on optimizing cellular nutrition through a personalized daily micronutrient membership. Rootine is differentiated in its process, unmatched data and insights, and unique delivery form factor. Rootine is helping thousands of members improve their health. Founded by Rachel Soper Sanders and Dr. Daniel Wallerstorfer, PhD in 2018, the company is building a remote-first team with headquarters in Nashville, TN. 

Lily Hecht-Leavitt,

View original content to download multimedia:

SOURCE Rootine

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.